Recommended pre-submission checks
Powered by 

Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Haidian-qu |
Planning to publish in Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology
Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Analysis of Test Results of Anti-HCV Reagents in Blood Screening Laboratory
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Clinical Characteristics and Prognostic Analysis of Patients with EBV-Positive Diffuse Large B-Cell Lymphoma
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Analysis of Factors Contributing to Apheresis Platelet Aggregation
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Cause Analysis of HLA-B Allele Missed Detection Based on AlltypeTM FastplexTM Next Generation Sequencing
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
The Clinical Value of Plasma cfTFEB and miR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Analysis of Test Results of Anti-HCV Reagents in Blood Screening Laboratory
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Clinical Characteristics and Prognostic Analysis of Patients with EBV-Positive Diffuse Large B-Cell Lymphoma
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Analysis of Factors Contributing to Apheresis Platelet Aggregation
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
Cause Analysis of HLA-B Allele Missed Detection Based on AlltypeTM FastplexTM Next Generation Sequencing
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi
The Clinical Value of Plasma cfTFEB and miR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma
- 1 Feb 2026
- Zhongguo shi yan xue ye xue za zhi